5 currently treat with 1 or 2 aeds any except oxc in a stable dose regimen during at least 1 month prior to screening patient use vigabatrin should have be on this medication for at least 1 year with no deficit in visual field identify a confirmatory test should be available within 1 month before study entry the device for vns should be implant at least 6 month before screen parameter need to be stable for at least 1 month prior to screening vns will not be count a concomitant aed 